Furthermore, HMGA2 expression has been shown to be associated with enhanced selective chemosensitivity towards the topoisomerase (topo) II inhibitor, doxorubicin, in breast cancer HS578T and salivary Pa-4/HMGA2 cells [2]. This evidence concerns the gene HMGA2 and breast carcinoma.